Strengthening market position in Germany through organic growth and acquisition

Ashfield first entered the German Commercial & Clinical market in 2012 through the acquisition of Pharmexx. Since then the business has grown, delivering revenue growth of over 84% between 2012 and 2017. Led by Benjamin Rapp and his team, Ashfield have won multiple projects with the top healthcare companies over the last two years, positioning Ashfield as the leading provider of Commercial & Clinical services in the market. Germany is the largest healthcare market in Europe and therefore it is a core growth market for UDG Healthcare and Ashfield.

Complementary to this strong organic growth, in May 2017, UDG Healthcare announced the acquisition of Sellxpert, a German and Swiss contract sales outsourcing business, based in Speyer, Germany and Basel, Switzerland. The acquisition significantly strengthens Ashfield’s presence and capabilities in Germany and accelerates its growth in the DACH* region.

Ashfield now works with 75 of the top healthcare companies, and employs approximately 1,100 talented employees in Germany. The focus for Ashfield Germany is on continuing to provide outstanding services for its clients and ensuring that they can attract the right employees to join the ever expanding team.

Benjamin Rapp
General Manager, DACH

* DACH: Germany, Austria and Switzerland.